Please provide your email address to receive an email when new articles are posted on . Ezetimibe conferred no increased risk for new-onset diabetes among IMPROVE-IT participants. The findings were ...
A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results